However, a high expression of ERα/PI3K was associated with tumours overexpressing HER2 (25% of tumours with a high expression of ERα/PI3K overexpressed HER2 vs. 10% of tumours with a low expression, p = 0.019). This evidence concerns the gene ERBB2 and neoplasm.